Search

everythinglearnresearchcommunity

for

Search:↓

Injectable minoxidil is a promising, effective treatment for hair loss.

Minoxidil sulfate, delivered through iontophoresis, can be used to treat hair loss.

Chitosan-decorated carriers may improve topical finasteride delivery for hair loss treatment.

Niosomes and ethosomes can effectively carry the drug spironolactone, potentially improving treatment for hair loss and reducing side effects.

Finasteride-loaded microemulsions, made with cinnamon oil, Tween20, propylene glycol, and water, can help maintain stemness of dermal cells, potentially aiding in hair regeneration.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Patients need long-term care after bariatric surgery to manage potential nutritional and metabolic issues.

Matriptase is crucial for keeping epithelial tissues healthy and functioning properly.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Foxi3 expression in developing teeth and hair is controlled by the ectodysplasin pathway.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Scientists have made progress in creating replacement teeth, hair, and glands that work, which could lead to new treatments for missing teeth, baldness, and dryness conditions.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Oral minoxidil improves hair density in women with androgenetic alopecia, with mild side effects.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

The document concludes that regenerating functional ectodermal organs like teeth and hair is promising for future therapies.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

SCDSFs from zebrafish embryos are beneficial for treating cancer, regenerating tissues, and improving conditions like psoriasis and alopecia.